Cabaletta Bio Newsroom

Wells Fargo Downgrades Cabaletta Bio(CABA.US) to Hold Rating, Cuts Target Price to $6

Moomoo NewsDec 20 13:41 ET

Evercore Initiates Cabaletta Bio(CABA.US) With Hold Rating, Announces Target Price $6

Moomoo NewsDec 20 13:31 ET

Analysts Conflicted on These Healthcare Names: Verastem (VSTM), Roche Holding AG (OtherRHHVF) and Cabaletta Bio (CABA)

TipRanksDec 20 12:22 ET

BofA Securities Cuts Price Target on Cabaletta Bio to $29 From $31, Keeps Neutral Rating

MT NewswiresDec 20 10:03 ET

Cabaletta Bio Cut to In-Line From Outperform by Evercore ISI Group

Dow JonesDec 20 06:48 ET

Evercore ISI Group Downgrades Cabaletta Bio to In-Line, Lowers Price Target to $6

BenzingaDec 20 06:38 ET

Cabaletta Bio Analyst Ratings

BenzingaDec 19 07:46 ET

Wells Fargo Downgrades Cabaletta Bio to Equalweight From Overweight, Cuts Price Target to $6 From $12

MT NewswiresDec 19 07:40 ET

H.C. Wainwright Maintains Cabaletta Bio(CABA.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsNov 19 13:31 ET

William Blair Maintains Cabaletta Bio(CABA.US) With Buy Rating

Moomoo NewsNov 18 04:33 ET

Cabaletta Bio Is Maintained at Overweight by Wells Fargo

Dow JonesNov 15 14:24 ET

H.C. Wainwright Maintains Cabaletta Bio(CABA.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsNov 15 11:33 ET

A Quick Look at Today's Ratings for Cabaletta Bio(CABA.US), With a Forecast Between $12 to $25

Moomoo NewsNov 15 08:03 ET

Cabaletta Bio Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Dow JonesNov 15 07:21 ET

Cabaletta Bio Analyst Ratings

BenzingaNov 15 07:11 ET

Analysts Offer Insights on Healthcare Companies: ACELYRIN, INC. (SLRN), Cabaletta Bio (CABA) and Mersana Therapeutics (MRSN)

TipRanksNov 15 05:32 ET

Cabaletta Bio's Promising Trial Results and Proactive Management Secure Buy Rating

TipRanksNov 14 11:18 ET

Stifel Maintains Cabaletta Bio(CABA.US) With Buy Rating, Maintains Target Price $26

Moomoo NewsNov 5 08:36 ET

Cabaletta Bio Analyst Ratings

BenzingaOct 10 09:29 ET

UBS Initiates Cabaletta Bio(CABA.US) With Buy Rating, Announces Target Price $10

Moomoo NewsOct 10 06:31 ET